Accumulating studies have shown that PPARGC1A promoted tumor growth (Bhalla et al., 2011; Vellinga et al., 2015), whereas several studies have found that the lower expression of this gene in COAD is associated with an increased risk of cancer (Feilchenfeldt et al., 2004). This evidence concerns the gene PPARGC1A and colon adenocarcinoma.